| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 06/05/2024 | 22:43 | Edgar (US Regulatory) | Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | NASDAQ:NVAX | Novavax Inc |
| 06/05/2024 | 12:22 | GlobeNewswire Inc. | Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting | NASDAQ:NVAX | Novavax Inc |
| 15/04/2024 | 12:00 | GlobeNewswire Inc. | Shah Capital nominates two highly qualified independent director candidates for Novavax | NASDAQ:NVAX | Novavax Inc |
| 01/04/2024 | 14:00 | PR Newswire (US) | Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024 | NASDAQ:NVAX | Novavax Inc |
| 06/03/2024 | 01:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NVAX | Novavax Inc |
| 29/02/2024 | 22:02 | PR Newswire (US) | Novavax to Participate in TD Cowen's 44th Annual Health Care Conference | NASDAQ:NVAX | Novavax Inc |
| 28/02/2024 | 14:07 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVAX | Novavax Inc |
| 28/02/2024 | 14:00 | PR Newswire (US) | Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights | NASDAQ:NVAX | Novavax Inc |
| 28/02/2024 | 13:30 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NVAX | Novavax Inc |
| 23/02/2024 | 14:03 | IH Market News | Goldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and More | NASDAQ:NVAX | Novavax Inc |
| 22/02/2024 | 12:00 | PR Newswire (US) | Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement | NASDAQ:NVAX | Novavax Inc |
| 20/02/2024 | 15:25 | PR Newswire (US) | Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024 | NASDAQ:NVAX | Novavax Inc |
| 03/01/2024 | 15:25 | PR Newswire (US) | Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference | NASDAQ:NVAX | Novavax Inc |
| 18/12/2023 | 14:00 | PR Newswire (US) | Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan | NASDAQ:NVAX | Novavax Inc |
| 13/12/2023 | 23:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:NVAX | Novavax Inc |
| 13/12/2023 | 14:31 | Dow Jones News | Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer | NASDAQ:NVAX | Novavax Inc |
| 13/12/2023 | 14:00 | PR Newswire (Canada) | Canadians Can Help Protect Loved Ones as We Head into the Holiday Season | NASDAQ:NVAX | Novavax Inc |
| 05/12/2023 | 22:01 | PR Newswire (US) | Novavax's Updated COVID-19 Vaccine Now Authorized in Canada | NASDAQ:NVAX | Novavax Inc |
| 28/11/2023 | 19:13 | IH Market News | Wall Street Radar: Amazon, Blackrock, General Motors, Eli Lilly, Novavax.. | NASDAQ:NVAX | Novavax Inc |
| 28/11/2023 | 12:00 | PR Newswire (US) | Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization | NASDAQ:NVAX | Novavax Inc |
| 17/11/2023 | 13:15 | PR Newswire (US) | Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities | NASDAQ:NVAX | Novavax Inc |
| 10/11/2023 | 15:25 | PR Newswire (US) | Novavax to Participate in Jefferies London Healthcare Conference | NASDAQ:NVAX | Novavax Inc |
| 09/11/2023 | 14:00 | PR Newswire (US) | Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights | NASDAQ:NVAX | Novavax Inc |
| 09/11/2023 | 13:32 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NVAX | Novavax Inc |
| 09/11/2023 | 13:02 | IH Market News | Thursday’s Wall Street Highlights: Nvidia, Duolingo, Disney, Virgin Galactic, Applovin, and more | NASDAQ:NVAX | Novavax Inc |
| 08/11/2023 | 12:59 | IH Market News | Wednesday’s Wall Street Highlights: Spirit AeroSystems, Upstart, Toast, Upwork, Take-Two, Sleep Number, and more | NASDAQ:NVAX | Novavax Inc |
| 02/11/2023 | 22:00 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:NVAX | Novavax Inc |
| 02/11/2023 | 14:25 | PR Newswire (US) | Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023 | NASDAQ:NVAX | Novavax Inc |
| 31/10/2023 | 21:48 | PR Newswire (US) | Novavax's Updated COVID-19 Vaccine Now Approved in the EU | NASDAQ:NVAX | Novavax Inc |
| 31/10/2023 | 18:08 | PR Newswire (US) | Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU | NASDAQ:NVAX | Novavax Inc |